Sequoia China, Boyu lead $160m Series B round in biotech startup Frontera

Sequoia China, Boyu lead $160m Series B round in biotech startup Frontera

Source: Frontera Therapeutics

20 July, 2022

biotech Boyu Capital Frontera Therapeutics Sequoia Capital China

Printed by Unregistered user on Fri, 04 Jul 2025 16:41:54 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Singapore biotech startup AMILI raises $10.5m in Vulcan-led Series A

Venture Capital

Indian biotech startup String Bio raises $20m from Australia's Woodside Energy

Read more from Greater China

China’s EV rivalry spills over to Thailand, tests local production goals

People Digest: responsAbility appoints CEO; Gaw Capital names data centre platform head